Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer.

So, Hee Jin; Hong, Seok-Il; Lee, Jin Kyung; Chang, Yoon Hwan; Kang, Sun Jung; Hong, Young Jun

So, Hee Jin; Hong, Seok-Il; Lee, Jin Kyung; Chang, Yoon Hwan; Kang, Sun Jung; Hong, Young Jun.

Afiliação

So HJ; Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul 139-709, Republic of Korea.
Hong SI; Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul 139-709, Republic of Korea ; Radiation Cancer Medicine Program, University of Science and Technology, Daejeon 305-350, Republic of Korea.
Lee JK; Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul 139-709, Republic of Korea ; Radiation Cancer Medicine Program, University of Science and Technology, Daejeon 305-350, Republic of Korea.
Chang YH; Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul 139-709, Republic of Korea ; Radiation Cancer Medicine Program, University of Science and Technology, Daejeon 305-350, Republic of Korea.
Kang SJ; Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul 139-709, Republic of Korea.
Hong YJ; Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul 139-709, Republic of Korea ; Radiation Cancer Medicine Program, University of Science and Technology, Daejeon 305-350, Republic of Korea.

Biomed Rep ; 2(5): 737-742, 2014 Sep.

Article em En | MEDLINE | ID: mdl-25054020

Palavras-chave

DR-70 immunoassay; biomarker; cytokeratin 19 fragment; fibrin-fibrinogen degradation products; lung cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Biomed Rep Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google